Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

300896 Imeik Technology Development

Watchlist
584.160
+2.810+0.48%
Market Close  02/08 15:00 CCT
High
594.440
Open
581.390
Turnover
537.44M
Low
579.870
Pre Close
581.350
Volume
9.14Klot
Market Cap
126.39B
P/E(TTM)
101.84
52wk High
646.000
Shares
216.36M
P/E(Static)
131.95
52wk Low
388.990
Float Cap
51.74B
Bid/Ask %
64.94%
Historical High
842.340
Shs Float
88.58M
Volume Ratio
0.73
Historical Low
168.735
Dividend TTM
2.1
Div Yield TTM
--
P/B
22.76
Dividend LFY
0.36%
Div Yield LFY
--
Turnover Ratio
1.03%
Amplitude
2.51%
Avg Price
588.088
Lot Size
100
Float Cap
51.74B
Bid/Ask %
64.94%
Historical High
842.340
Shs Float
88.58M
Volume Ratio
0.73
Historical Low
168.735
Dividend TTM
2.1
Limit Up
697.620
P/B
22.76
Dividend LFY
0.36%
Limit Down
465.080
Turnover Ratio
1.03%
Amplitude
2.51%
Avg Price
588.088
Lot Size
100
Ask
3.46Klot
Bid
4.72Klot
Price Forecast

News

Comment

Company Overview More
Hermione Technology Development Co., Ltd. is a joint stock company established on the basis of Beijing Emaker Biotechnology Co., Ltd. through an overall change. On June 24, 2016, it obtained a business license issued by the Changping Branch of the Beijing Administration for Industry and Commerce with a unified social credit code of 9111011114763510383J, with a registered capital and share capital of RMB 85.662 million. The company is an innovative leading enterprise in the field of biomedical soft tissue repair materials in China. Based on the development and transformation of biomedical soft tissue repair materials, the company has successfully industrialized a series of dermal fillers based on sodium hyaluronate, dermal fillers based on polylactic acid, and polydioxycyclohexanone facial implants. At the same time, it is developing biomedical products such as recombinant proteins and peptides. The company's current main products are: a series of dermal fillers based on sodium hyaluronate, dermal fillers based on poly-L-lactic acid, facial implant line products, and a derived “companion” cosmetic brand matrix.
CEO: --
Market: --
Listing Date: 09/28/2020
Futu Hot List
CNHKUS
SearchNews
SymbolLatest price%Chg

Loading...

Watchlist